SCHEMBL5025840

SCHEMBL5025840

NCN(CN)NC(=O)C[C@H](N)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)cc1)C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 1/20 0.43
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
SCN9A Q15858 1/20 0.41
ADCY6 O43306 1/20 0.41
ADCY3 O60266 1/20 0.41
ADCY9 O60503 1/20 0.41
ADCY5 O95622 1/20 0.41
ADCY8 P40145 1/20 0.41
GCGR P47871 1/20 0.41
ADCY7 P51828 1/20 0.41
ADCY2 Q08462 1/20 0.41
ADCY1 Q08828 1/20 0.41
ADCY4 Q8NFM4 1/20 0.41
MCHR1 Q99705 1/20 0.40
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
HDAC4 P56524 4/20 0.39
HDAC1 Q13547 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5018248 0.95 BDKRB2 (0.43) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018301 0.89 BDKRB2 (0.44) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018502 0.88 BDKRB2 (0.43) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018249 0.86 BDKRB2 (0.46) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018483 0.86 BDKRB2 (0.42) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL10084095 0.86 BDKRB2 (0.42) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018144 0.86 BDKRB2 (0.43) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018488 0.86 BDKRB2 (0.43) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018157 0.86 BDKRB2 (0.43) BDKRB2CNR1CNR2SCN9AADCY6
SCHEMBL5018302 0.85 BDKRB2 (0.46) BDKRB2CNR1CNR2SCN9AADCY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 US disclosed